Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Shear-Induced Unfolding and Enzymatic Cleavage of Full-Length VWF Multimers.

Lippok S, Radtke M, Obser T, Kleemeier L, Schneppenheim R, Budde U, Netz RR, Rädler JO.

Biophys J. 2016 Feb 2;110(3):545-54. doi: 10.1016/j.bpj.2015.12.023.

PMID:
26840720
2.

Successful aortic aneurysm repair in a woman with severe von Willebrand (type 3) disease.

Campbell V, Marriott K, Stanbridge R, Shlebak A.

Case Rep Hematol. 2015;2015:703803. doi: 10.1155/2015/703803. Epub 2015 Apr 19.

3.

A novel snake venom-derived GPIb antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury.

Li TT, Fan ML, Hou SX, Li XY, Barry DM, Jin H, Luo SY, Kong F, Lau LF, Dai XR, Zhang GH, Zhou LL.

Br J Pharmacol. 2015 Aug;172(15):3904-16. doi: 10.1111/bph.13178. Epub 2015 Jun 12.

4.

Conventional rapid latex agglutination in estimation of von Willebrand factor: method revisited and potential clinical applications.

Mahat M, Abdullah WZ, Hussin CM.

J Immunol Res. 2014;2014:850810. doi: 10.1155/2014/850810. Epub 2014 Dec 25.

5.

Circulating but not immobilized N-deglycosylated von Willebrand factor increases platelet adhesion under flow conditions.

Fallah MA, Huck V, Niemeyer V, Desch A, Angerer JI, McKinnon TA, Wixforth A, Schneider SW, Schneider MF.

Biomicrofluidics. 2013 Aug 26;7(4):44124. doi: 10.1063/1.4819746. eCollection 2013.

6.

The molecular genetics of von Willebrand disease.

Berber E.

Turk J Haematol. 2012 Dec;29(4):313-24. doi: 10.5505/tjh.2012.39205. Epub 2012 Dec 5. Review.

7.

Exponential size distribution of von Willebrand factor.

Lippok S, Obser T, Müller JP, Stierle VK, Benoit M, Budde U, Schneppenheim R, Rädler JO.

Biophys J. 2013 Sep 3;105(5):1208-16. doi: 10.1016/j.bpj.2013.07.037.

8.

Antihemophilic Factor/von Willebrand Factor Complex (Human), Dried, Pasteurized.

[No authors listed]

P T. 2010 Jan;35(1 Section 2):2-24. No abstract available.

10.

A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF.

Zanardelli S, Chion AC, Groot E, Lenting PJ, McKinnon TA, Laffan MA, Tseng M, Lane DA.

Blood. 2009 Sep 24;114(13):2819-28. doi: 10.1182/blood-2009-05-224915. Epub 2009 Jul 8.

11.

Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications.

Franchini M, Capra F, Targher G, Montagnana M, Lippi G.

Thromb J. 2007 Sep 25;5:14.

12.

Corynebacterium diphtheriae employs specific minor pilins to target human pharyngeal epithelial cells.

Mandlik A, Swierczynski A, Das A, Ton-That H.

Mol Microbiol. 2007 Apr;64(1):111-24.

13.

Phenotypic correction of von Willebrand disease type 3 blood-derived endothelial cells with lentiviral vectors expressing von Willebrand factor.

De Meyer SF, Vanhoorelbeke K, Chuah MK, Pareyn I, Gillijns V, Hebbel RP, Collen D, Deckmyn H, VandenDriessche T.

Blood. 2006 Jun 15;107(12):4728-36. Epub 2006 Feb 14.

Items per page

Supplemental Content

Write to the Help Desk